Stock Movers

On this episode of Stock Movers:

- Share of AppLovin (APP) gains as Much as 7.2%. Wells Fargo analyst Alec Brondolo raised the firm's price target on AppLovin (APP) to $560 from $543 and keeps an Overweight rating on the shares. The firm says checks are improving and buy-side sentiment is negative. Wells sees positive setup into Q1 EPS.

- Tesla (TSLA) falls to its lowest since September. Shares fell as much as 3.9% In the wake of a delivery-forecast miss from Tesla, JPMorgan's Ryan Brinkman highlighted that the company was also up against a much lower bar than had been expected years ago.

- Bank of New York Mellon (BNY) shares rose as much as 1.7% and Robinhood Markets (HOOD) shares gained as much as 2.3% after the firms were tapped by the US Treasury to support the implementation of the new Trump Accounts program.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Isabelle Lee, Carol Massar and Tim Stenovec.

- Seagate (STX) shares are up after Morgan Stanley raised its price target on the computer hardware and storage company to $582 from $468. The firm also named Seagate its Top Pick, seeing long-term tailwinds related to AI.

- Tesla (TSLA) stocks are down after JPMorgan analyst Ryan Brinkman said "Tesla investors should proceed with caution because the electric-vehicle maker is in danger of weaker performance." He cut his earnings estimates for the company after first-quarter delivery numbers disappointed last week.

- Invesco (IVZ) shares fell after BlackRock Inc. announced it was setting its sights on a corner of the $13.7 trillion US exchange-traded fund industry long controlled by Invesco: tracking the Nasdaq 100 Index.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Micron (MU) shares rise after a KeyBanc analyst John Vinh repeated an Overweight rating. This comes as Micron Technology Inc. is facing challenges in the stock market, with its shares down nearly 20% since hitting a high three weeks ago due to concerns about the memory sector and uncertainty in the broader market.
- Dow (DOW US) shares drop. US chemical stocks are lower on Monday as oil prices pull back and BofA downgrades the stocks as it sees the market tailwinds from the Iran war as unsustainable.
- Carvana (CVNA) shares fall. BofA Global Research downgraded the online used-car retailer to neutral from buy citing recent macro and industry developments.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Carvana shares (CVNA) falls. BofA Global Research downgrades the online used-car retailer to neutral from buy citing recent macro and industry developments. Analyst Michael McGovern says with “the recent oil shock potentially pressuring an already stretched lower & middle income consumer, and 2-year rates moving the opposite direction, we think the risk/reward profile is more balanced now.”
- Netflix shares (NFLX) are up after Goldman Sachs upgraded the streaming-video company to buy from neutral. “We expect NFLX’s upcoming earnings report to reflect a strong start to 2026 as management continues to execute well against its core areas of strategic focus,” writes analyst Eric Sheridan.
- Tyson Foods shares (TSN) rise as Piper Sandler upgrades to overweight from neutral citing potential near-term catalysts in beef and chicken. Analyst Michael Lavery says Tyson “has strong top-line momentum with its portfolio benefitting from consumer shifts to more protein.”
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Gulf Funds Agree to Back Paramount's $81 Billion Takeover of Warner
- Netflix (NFLX) shares are up after Goldman Sachs upgraded the streaming-video company to buy from neutral.
- Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion to expand in rare genetic disorders. The biotechnology company will pay $53 per share for Soleno, a 34% premium to its closing share price Thursday, using cash on hand and some pre-payable debt. Both company boards have approved the transaction, which is expected to close within 90 days.
See omnystudio.com/listener for privacy information.